Finally, it has already been shown that HMGA1 overexpression is associated with patients’ poor outcome in several human neoplasias, such as colon carcinomas [33,34], pancreatic adenocarcinomas [35,36], non-small cell lung cancer [37] and breast tumors [38]. This evidence concerns the gene HMGA1 and pancreatic adenocarcinoma.